Article

Pharmacy Quiz: Test Your Knowledge on Multiple Sclerosis Treatments

Author(s):

Saro Arakelians, PharmD

Ten quiz questions to assess your knowledge on common multiple sclerosis treatments.

Kesimpta is the brand name for which of the below medications?


Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit: kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Breast cancer cell | Image Credit: © Mopic - stock.adobe.com
July 9th 2025

Obesity-Linked Exosomes May Drive Tumor Aggressiveness in Triple-Negative Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
July 9th 2025

Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies

Jennifer D. Goldman, PharmD, CDE, BC-ADM, FCCP Alana Hippensteele, Lead Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Microscopic view of breast cancer cells | Image Credit: © Jack - stock.adobe.com
July 8th 2025

Radiation or Immune-Modulating Drugs Could Mitigate Resistance to CDK4/6 Inhibitors in Breast Cancer

Alexandra Gerlach, Associate Editor
Redefining Pharmacovigilance Through Digital Innovation
July 8th 2025

Redefining Pharmacovigilance Through Digital Innovation

Aabha Daryapurkar, PharmD